Latest New Zealand News

Atomo Diagnostics has closed a modest Share Purchase Plan, raising $44,500 and issuing free attaching options, while reserving a substantial shortfall for future placement.

ANZ is executing a $248 million on-market share buyback via UBS to neutralise shares issued under its Dividend Reinvestment Plan for the 2026 interim dividend, with a 12-day pricing period ending 1 June 2026.

Gratifii Limited has secured $10 million in new capital to acquire Simplicity Loyalty and invest strategically in Marketplacer, aiming to broaden its loyalty and rewards platform across Australia and New Zealand.

AVITA Medical reported a 4% revenue increase in Q1 2026 with a narrowed net loss, underpinned by a new BARDA contract and promising Cohealyx clinical data. Leadership changes and regulatory approvals support a confident outlook.

Pacific Edge edges closer to a Medicare breakthrough with a draft Local Coverage Determination proposing coverage for its Cxbladder Triage and Triage Plus tests, potentially unlocking reimbursement for over 66 million US patients.

Meridian Energy's April 2026 operating report highlights robust hydro inflows and retail sales growth while electricity futures prices continue to decline.

Syntara Limited offers existing shareholders a discounted share purchase plan to raise about $2 million, following a recent $8 million institutional placement to fund clinical trials and licensing.

oOh!media posts solid early 2026 revenue growth and launches a $12 million annual savings program, while exiting retail media and navigating takeover bids.

Bapcor reports a turnaround in sales momentum after February 2026 but lowers its full-year earnings forecast due to geopolitical and cost pressures.

Critical Resources has lodged an application to extend its Croesus gold-tungsten permit in New Zealand, targeting a broader tungsten system with historic grades up to 42.6% WO3. This move comes as tungsten prices surge over eightfold due to global supply constraints.

Pacific Edge launches a NZ$6 million retail share offer at NZ$0.17 per share following a NZ$25.4 million institutional placement, aiming to strengthen its balance sheet and support Medicare reimbursement efforts for its bladder cancer diagnostics.

Smart Parking Limited grew its ANPR sites by 17% in Q3 FY26 and increased parking breach notices by 19%, leveraging acquisitions and AI technology to expand across Europe and New Zealand.